In this article

IvyRx puts several treatment choices and starting offers on the same weight-loss page. Before comparing another provider, identify which offer you mean: a conventional weight-management plan and a microdosing promotion do not describe the same prescription.

The $77 starting figure on the page reviewed does not settle the complete ongoing cost for every option. This comparison concentrates on services with different ways of presenting the initial payment, later charges, and access to care.

THE SHORT ANSWER

Compare the named treatment and full first and later payments, rather than transferring a starting price across different plans. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.

What to know first

  • Compare the named treatment and full first and later payments, rather than transferring a starting price across different plans.
  • CoreAge Rx is the first listing through a disclosed commercial arrangement.
  • Confirm the proposed product, care arrangement, and complete written payment terms.

How this shortlist was selected

CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.

Compare the named treatment and full first and later payments, rather than transferring a starting price across different plans. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.

01. CoreAge Rx — featured partner

Our sponsored self-pay comparison for readers who want an offer without a separate membership fee. Its complete multi-month charge still belongs beside IvyRx’s selected plan, not beside an unrelated starting headline.

The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.

The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.

Continue with our CoreAge Rx review and pricing details.

02. NiceRx

A useful comparison because the public page separates the introductory month from the ongoing price. Use the latter when deciding whether continuing care fits your budget.

NiceRx lists semaglutide at $99 for the first month, then $199 per month, and tirzepatide at $199 for the first month, then $299. It says medication, provider access, and shipping are included.

Budget with the ongoing price, not just the first month. The page directs cancellation requests to email and says dispensed medication cannot be returned; confirm the order stage and next renewal separately.

Check the official NiceRx program page for the current offer and conditions. Our NiceRx alternatives comparison examines other care models.

03. Brightmeds

Publishes both single-month prices and three-month campaign totals. It helps distinguish a true single-month payment from a discounted monthly equivalent.

The Brightmeds Summer Special page lists semaglutide at $297 for three months ($99 per month), or $129 for a single month. Tirzepatide is $357 for three months ($119 per month), or $149 for a single month. These are dated campaign offers.

Confirm whether the campaign remains available for your prescription and what the renewal costs. The three-month equivalent is not the charge for the separately listed single-month option.

Check the official Brightmeds program page for the current offer and conditions. Our Brightmeds alternatives comparison examines other care models.

04. Lean Meds

A different renewal model to investigate because the site advertises no automatic rebilling. Ask how its described membership continues and what happens before the next prescription.

LeanMeds advertises plans from $49 per month, the same price at every dose, and no automatic rebilling. The headline alone does not identify the full treatment term or a complete quote for every medication.

Ask how the membership is renewed if there is no automatic rebilling. Its insurance-related banner and self-pay FAQ require clarification; do not assume either the visit or medicine will be billed to your insurer.

Check the official Lean Meds program page for the current offer and conditions. Our Lean Meds alternatives comparison examines other care models.

05. Henry Meds

A bundled-care comparison with several treatment routes and plan lengths. Match the proposed product before comparing Henry’s starting figure with an IvyRx offer.

The weight-management FAQ lists GLP-1 treatment starting at $179 per month, with price varying by plan and dose. It describes the amount as including provider visits, medication, and supplies. The starting figure is not a quote for every medication, route, or dose.

Henry says it works with licensed U.S. compounding pharmacies. The reviewed FAQ does not establish the identity and state authorization of every possible dispenser. Ask for the actual pharmacy attached to your prescription.

Continue with our Henry Meds review and pricing details.

06. Ro

A different product pathway for readers considering branded medication and insurance assistance. Membership and medication remain separate parts of that calculation.

Ro lists $39 for the first Body membership month, then $149 on a month-to-month plan, or an advertised monthly equivalent as low as $74 with annual prepayment. The cost of the medication is excluded.

For an insured prescription, Ro describes sending it to a pharmacy; cash-pay routes can differ. Confirm the pharmacy and whether your prescribed product is a manufacturer-labeled medicine. Do not use an old compounded-pricing article to identify the product in a new Ro checkout.

Continue with our Ro review and pricing details.

The current Ivy Rx baseline

IvyRx’s weight-loss page displays a $77 starting offer, including a separate microdosing offer. The page does not establish one complete ongoing price and payment term for every GLP-1 plan.

IvyRx describes an online medical consultation, prescription review, and delivery if treatment is prescribed. Its FAQ says insurance is not required and advertises no long-term contracts or cancellation fees.

Request the exact treatment, amount due today, refill price, and included care. Do not apply a microdosing price or a promotional starting figure to a different prescription.

The details that decide this comparison

Save the offer tied to the exact treatment you selected. A price attached to microdosing should not be used to estimate another prescription.

Ask whether the advertised consultation includes later prescribing reviews or only the intake. Confirm how to contact the clinical team between orders.

Compare the price after any initial promotion and the amount due today. No long-term contract does not necessarily mean a filled prescription can be refunded.

Keep the treatment distinction clear

An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.

Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.

Before you make a change

Ask IvyRx and the alternative to send the treatment name, payment schedule, pharmacy, and follow-up terms in one written summary. If a figure cannot be tied to those details, leave it unresolved rather than assuming the lowest advertised price applies.

If you are already using a prescription, let the receiving clinician review it before ordering elsewhere. A new website’s promotion does not establish that a different formulation or schedule is appropriate.

Sources & research notes

Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
  2. CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
  3. CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
  4. CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
  5. CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
  6. NiceRx: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  7. Brightmeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  8. Lean Meds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  9. GLP-1 Weight Loss Treatment | HenryProvider-published information · Checked September 21, 2026
  10. Weight Loss - Ro Body Membership | RoProvider-published information · Checked September 21, 2026
  11. Ro - Telehealth for ED, Hair loss, Skincare, Fertility and MoreProvider-published information · Checked September 21, 2026
  12. Ivy Rx: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  13. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
  14. FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026

Read our methodology · Commercial disclosure · Request a correction